期刊文献+

卵巢癌组织BRCA1转录调节:启动子位点1-2高甲基化介导的组蛋白修饰H3K9ac富集丢失 被引量:4

Regulation of BRCA1 transcription in ovarian cancer: A crosstalk between sites 1 and 2 hypermethylation and loss of H3K9 ac enrichment
下载PDF
导出
摘要 目的:探讨卵巢癌组织介导BRCA1转录调节的甲基化机制。方法:利用实时荧光定量PCR方法检测卵巢癌组织中BRCA1的表达样式;采用焦磷酸测序技术分析卵巢癌标本BRCA1基因启动子区域位点1和2的甲基化水平;采用染色质免疫共沉淀研究BRCA1启动子区域差异甲基化位点周边组蛋白H3K9ac富集情况。结果:卵巢癌组织BRCA1启动子高甲基化常常伴随BRCA1表达水平降低; BRCA1启动子区域位点1和2的异常甲基化是其转录调节的重要机制;位点1和2异常高甲基化介导的H3K9ac富集水平降低显著抑制BRCA1转录。结论:在卵巢癌组织中,BRCA1基因启动子的异常甲基化及其介导的差异组蛋白修饰H3K9ac富集协同参与BRCA1的转录调控。 Objective:To investigate the expression of BRCA1 in ovarian cancer specimens,and provide novel insight into the DNA methtlation involved in BRCA1 transcription.Methods:BRCA1 level was analysed by real-time quantitative PCR.The methylation level of BRCA1 core promoter (sites 1 and 2) was determined using pyrosequencing.Chromatin immunoprecipitation was used for detecting the H3K9ac pattern.Results:High methylation levels of sites 1 and 2 in the BRCA1 core promoter were accompanied by decreasing BRCA1 expression.Hypermethylated sites 1 and 2 were a key regulatory element for the BRCA1 transcription.Mechanistically,the abnormal sites 1 and 2 methylation-mediated loss of H3K9ac enrichment inhibited the transcription of BRCA1.Conclusion:Our findings imply that epigenetic mechanisms (such as DNA methylation and histone modification) are jointly involved in BRCA1 transcription in ovarian cancer.
作者 毕芳芳 杨清 Bi Fangfang;Yang Qing(Department of Obstetrics and Gynecology,Shengjing Hospital of China Medical University,Liaoning Shenyang 110004,China)
出处 《现代肿瘤医学》 CAS 2018年第23期3731-3734,共4页 Journal of Modern Oncology
基金 辽宁省博士科研启动基金指导计划项目(编号:201601128)
关键词 BRCA1 表观遗传学 DNA甲基化 H3K9ac 卵巢癌 BRCA1 epigenetic DNA methylation H3K9ac ovarian cancer
  • 相关文献

参考文献3

二级参考文献66

  • 1Robertson KD, Jones PA. DNA methylation: past, present and future directions. Carcinogenesis 2000; 21:461-467.
  • 2Agrawal A, Murphy R_F, Agrawal DK. DNA methylation in breast and colorectal cancers. ModPatho12007; 20:711-721.
  • 3Siedlecki P, Zielenkiewicz P. Mammalian DNA methyltransferases. Acta Biochim Pol 2006; 53:245-256.
  • 4Lafon-Hughes L, Di Tomaso MV, Mendez-Acuna L, Martinez-Lopez W. Chromatin-remodelling mechanisms in cancer. Mutat Res 2008; 658:191-214.
  • 5Esteller M. Cancer epigenetics: DNA methylation and chromatin alterations in human cancer. Adv Exp Med Biol 2003; 532:39-49.
  • 6Soares J, Pinto AE, Cunha CV, et aL Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression. Cancer 1999; 85:112-118.
  • 7Jackson K, Yu MC, Arakawa K, et al. DNA hypomethylation is prevalent even in low-grade breast cancers. Cancer Biol Ther 2004; 3:1225-1231.
  • 8Jeltsch A. Molecular enzymology of mammalian DNA methyltransferases. Curr Top Microbiol Immunol 2006; 301:203- 225.
  • 9Bonfini L, Karlovich CA, Dasgupta C, Banerjee U. The son of sevenless gene product: a putative activator of Ras. Science 1992; 255:603-606.
  • 10Gonzalo S, Jaco I, Fraga MF, et al. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 2006; 8:416-424.

共引文献20

同被引文献38

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部